Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2005 | 03-2005 | 12-2004 | 09-2004 | 06-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,920 | -5,070 | -19,370 | -14,090 | -9,510 |
| Depreciation Amortization | 320 | 200 | 800 | 590 | 380 |
| Other Working Capital | -500 | -430 | 710 | 40 | 660 |
| Other Operating Activity | 4,460 | -20 | 380 | 340 | 350 |
| Operating Cash Flow | $-9,640 | $-5,320 | $-17,480 | $-13,120 | $-8,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -40 | -320 | -300 | -160 |
| Other Investing Activity | 1,490 | 1,490 | 9,830 | 9,840 | 6,660 |
| Investing Cash Flow | $1,420 | $1,450 | $9,510 | $9,540 | $6,500 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -250 | 0 | -500 | -250 | -250 |
| Other Financing Activity | 3,700 | 3,750 | 9,550 | 9,260 | 9,250 |
| Financing Cash Flow | $3,450 | $3,750 | $9,050 | $9,010 | $9,000 |
| Beginning Cash Position | 16,250 | 16,250 | 15,160 | 15,160 | 15,160 |
| End Cash Position | 11,480 | 16,140 | 16,250 | 20,590 | 22,540 |
| Net Cash Flow | $-4,760 | $-100 | $1,080 | $5,430 | $7,380 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,640 | -5,320 | -17,480 | -13,120 | -8,120 |
| Free Cash Flow | -9,640 | -5,320 | -17,480 | -13,120 | -8,120 |